Back to MPT Database

Yaso-GEL

Also considered to be developed as vaginal ovule or film. Non-hormonal contraceptive option. Antiviral and antibacterial properties.

Development Stage:

Preclinical – Advanced (Pre2)

Hormonal/Non-Hormonal:

Non-Hormonal

Delivery Route & Method:

Topical - Gel-Vaginal

Mechanism of Action:

Polyanion

Developer:

  • Yaso Therapeutics

Funding:

  • Nat. Institute Child Health & Human Development (NICHD)

Funding Mechanism:

Phase 2B SBIR

Past Funding:

NIH: SBIR

Active Ingredient(s):

  • Polyphenylene Carboxymethylene (PPCM)

Product Indication(s):

  • Chlamydia
  • Gonorrhea
  • HIV
  • HPV
  • HSV-2
  • Pregnancy

Back to MPT Database